| Literature DB >> 22829758 |
George K Acquaah-Mensah1, Deepti Malhotra, Madhulika Vulimiri, Jason E McDermott, Shyam Biswal.
Abstract
Chronic obstructive pulmonary disease (COPD) is a major global health problem. The etiology of COPD has been associated with apoptosis, oxidative stress, and inflammation. However, understanding of the molecular interactions that modulate COPD pathogenesis remains only partly resolved. We conducted an exploratory study on COPD etiology to identify the key molecular participants. We used information-theoretic algorithms including Context Likelihood of Relatedness (CLR), Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNE), and Inferelator. We captured direct functional associations among genes, given a compendium of gene expression profiles of human lung epithelial cells. A set of genes differentially expressed in COPD, as reported in a previous study were superposed with the resulting transcriptional regulatory networks. After factoring in the properties of the networks, an established COPD susceptibility locus and domain-domain interactions involving protein products of genes in the generated networks, several molecular candidates were predicted to be involved in the etiology of COPD. These include COL4A3, CFLAR, GULP1, PDCD1, CASP10, PAX3, BOK, HSPD1, PITX2, and PML. Furthermore, T-box (TBX) genes and cyclin-dependent kinase inhibitor 2A (CDKN2A), which are in a direct transcriptional regulatory relationship, emerged as preeminent participants in the etiology of COPD by means of senescence. Contrary to observations in neoplasms, our study reveals that the expression of genes and proteins in the lung samples from patients with COPD indicate an increased tendency towards cellular senescence. The expression of the anti-senescence mediators TBX transcription factors, chromatin modifiers histone deacetylases, and sirtuins was suppressed; while the expression of TBX-regulated cellular senescence markers such as CDKN2A, CDKN1A, and CAV1 was elevated in the peripheral lung tissue samples from patients with COPD. The critical balance between senescence and anti-senescence factors is disrupted towards senescence in COPD lungs.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22829758 PMCID: PMC3400575 DOI: 10.1371/journal.pcbi.1002597
Source DB: PubMed Journal: PLoS Comput Biol ISSN: 1553-734X Impact factor: 4.475
Figure 1A view of the outline of the approaches used in this study.
A combination of network inference and other algorithms applied to the datasets as described in the Materials and Methods section, led to the nodes of interest identified in the networks.
Figure 2Quantitative PCR data indicate TBX3, TBX5, HDAC6, SIRT1, SIRT6 gene expression is suppressed in the lungs of patients with COPD, while mRNA expression of HDAC2 does not change compared to lung tissue from normal smokers.
The extent of the suppression is highly significant between patients with mild and those with severe COPD. Patient diagnosis was based on the National Heart, Lung, and Blood Institute/World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD) [146]. Fifteen normal, nine mild COPD, and six severe COPD samples were used for this analysis. The data is represented as Mean ± S.D. The data was analyzed using student's t-test for comparing mRNA expression in the respective groups. *represents a significance of p-value<0.01.
Proportion and list of direct neighbors also asserted in initial networks generated via other mutual information—based algorithm.
| GENE | CLR | ARACNE | DIRECT NETWORK NEIGHBORS FOUND BY BOTH ALGORITHMS |
|
| 80/84 | 80/347 | ACTN1 ACTN3 ACVR1B AIFM2 AVEN BAX BCL2L1 BCL2L10 BCL3 BCLAF1 BID BIRC7 BOK CASP10 CD74 CDK5R1 CDKN2D CECR2 CIDEA CLCF1 COL4A3 CRYAA DAPK2 DAPK3 DIABLO DLC1 DOCK1 F2 FOXO1 FURIN GLRX2 HIP1 IGF1R IL3 IL4I1 KIAA1967 KNG1 KRT18 LYST MAP3K10 MAPK1 MAPK8IP2 NCR1 NLRP12 NME1 NME2 NME5 NOL3 NPM1 PAX3 PCSK6 PDCD5 PDIA2 PHLDA2 PRKAA1 PRKCA PRKCZ PRLR RNF7 RTKN SCIN SEMA6A SERPINB2 SERPINB9 SFRP1 SMAD3 SOCS3 SPATA3 SST SSTR3 TBX5 TGFB1 TGFB2 TIA1 TIAL1 TLR2 TNFRSF19 TNFSF10 TP53 TRIAP1 |
|
| 37/45 | 37/180 | ACTN1 ACTN3 ADORA1 AGTR2 ALOX15B BBC3 BCL2 BCL2L1 BOK CD74 CDK5R1 CDKN2D CECR2 COL4A3 DNM2 GRM4 HSPD1 KNG1 LYST MAPK1 MAPK8 MPO NLRP12 PAX3 PDCD1 PDCD6 PDIA2 PRKCA PTEN RHOB RHOT1 SEMA6A SNCA SOCS3 TBX3 TIA1 TRAF7 |
|
| 44/60 | 44/189 | ADAMTSL4 ANXA1 ANXA4 API5 BBC3 BCL2 BCL2A1 BCLAF1 BTG1 CADM1 CASP8AP2 CD38 CDC2L2 CFLAR CRADD CYFIP2 DAPK2 DAXX DEDD2 EIF5A FASLG GCLC GULP1 HDAC3 HMGB1 IL1A MAPK8IP2 MCL1 NLRP1 NOTCH2 NOX5 PCSK6 PDCD1 PDIA2 PIK3R2 PML PRKCA PRKCE SPHK1 TAOK2 TGFB1 TNFRSF25 TNFRSF6B TP63 |
Figure 3Patients with COPD have suppressed TBX2 and increased CDKN2A, CDKN1A, and caveolin-1 mRNA and protein expression.
A) Quantitative PCR data indicate TBX2 gene expression is suppressed, while senescence factors, CDKN2A, CDKN1A, and caveolin-1 are induced in the lungs of patients with COPD compared to lung tissue from normal smokers. Fifteen normal, nine mild COPD, and six severe COPD samples were used for this analysis. The data is represented as Mean ± S.D. The data was analyzed using student's t-test for comparing mRNA expression in the respective groups. B) Representative Western blots showing suppressed TBX2, HDAC2, SIRT1 proteins and increased expression of CDKN2A, CDKN1A and caveolin-1 proteins in samples from patients with COPD. C) Densitometry analysis of Western blot data. Four normal, four mild COPD, and four severe COPD samples were used for this analysis. Densitometry analysis was carried out using image-J software. The data is represented as Mean ± S.D. The data was analyzed using student's t-test for comparing protein expression in the respective groups. *represents a significance of p-value<0.01.
Examples of genes within Biclusters (of five, ten, and twenty Biclusters identified using FABIA).
| Number of Biclusters Learned | Bicluster Number | Probe sets Present | Arrays Present | Some Genes Present | Description of Array Samples In Bicluster |
|
| Bicluster #4 | 924 | 35 |
|
|
|
| Bicluster #3 | 1749 | 30 |
|
|
|
| Bicluster #2 | 2096 | 30 |
|
|
|
| Bicluster #8 | 1991 | 44 |
|
|
|
| Bicluster #13 | 567 | 56 |
|
|
*: Bronchoalveolar lavage samples obtained from lung transplant recipients whose biopsies had a perivascular score of between 0 and 2, and a bronchiolar score of between 0 and 1 [147].
**: Lung epithelial cell transcriptome study of 34 current smokers, 18 former smokers, and 23 subjects who had never smoked [148].
Inferelator predictions of regulators of twenty Biclusters generated using FABIA.
| BICLUSTER∧ | NUMBER OF PROBESETS | NUMBER OF OBSERVATIONS | CLUSTER PROBABLY POSITIVELY REGULATED BY*** | CLUSTER PROBABLY NEGATIVELY REGULATED BY*** |
|
| 2084 | 32 | TBX3, ELF3 | ATF2_with_HSF1 |
|
| 2096 | 30 | CEBPG, ATF1 | PML, TP63, TBX5, TBX5_with_NFKBIB, PPARD_with_SMAD3 |
|
| 1560 | 31 | CEBPG_with_TP63, NME1-NME2, TCF7L2, TIAL1 | |
|
| 1569 | 38 | NFE2L2_with_CDKN1A, STAT1 | TCF7L2 |
|
| 2619 | 35 | STAT5B_with_TP63, SMAD3 | HTATIP2 |
|
| 1705 | 35 | RUNX3 | E2F1_and_TCFL2 , HTATIP2 |
|
| 1381 | 38 | STAT1, CREBBP | E2F1, LOC652346, PML_with_TBX2, TBX5 |
|
| 1991 | 44 | STAT5B, NFATC3 | TCF7L2, TCF7L2_with_TIAL1 |
|
| 1089 | 33 | NLRP3, SMAD3, RUNX3 | |
|
| 967 | 47 | SIGIRR | |
|
| 806 | 32 | RUNX3, RUNX3_with_SMAD3 | ATF2, EP300_with_TBX2, TCF7L2 |
|
| 566 | 34 | TP63_and_STAT1 | CEBPB, TCF7L2 |
|
| 567 | 56 | FOXO3, SMAD3_with_ERC1, ELF3 | STAT5A |
|
| 493 | 50 | ARHGDIA_with_RUNX3, RUNX3 | PML, E2F1 |
|
| 754 | 45 | ELF3 | CREB1_with_TIAL1 |
|
| 356 | 43 | PML_with_HSF1, LOC161527, HSF1, SBNO2 | |
|
| 510 | 46 | SBNO2, JUN, RUNX3_with_CREB1,JUN_with_TP53, TP63 | NFATC4_with_HTATIP2 |
|
| 380 | 61 | ELF3_with_BCL10 | ATF1 |
|
| 347 | 47 | SMAD3 | TGFB1_with_GOLGA6L4, STAT5A |
|
| 497 | 50 | HIF1A, STAT1, STAT5B, RELA | HSF1_with_TBX5 |
| ∧Obtained using FABIA algorithm | ****Per Inferelator predictions | |||
Figure 4A) The state of the Type IV collagen alpha 3 subunit, COL4A3, depends on the states of both TBX2 and CDKN2A in human lung epithelial cells. Following Robust Multi-Array Analysis of a compendium of 109 Affymetrix arrays on the U133A platform, the Context Likelihood of Relatedness (CLR) algorithm was used to generate a transcriptional regulatory network involving all available probe sets (at a CLR likelihood estimate cut-off of 2.5). Olive-green nodes represent genes whose median probe set expressions are suppressed in COPD. White nodes represent genes whose median probe set expressions are elevated in COPD. COL4A3, whose expression is suppressed in the COPD lung, is thus statistically dependent on both TBX2 and CDKN2A. B) Evolutionarily conserved probable protein domain-domain interactions corresponding to the predictions of Table 5. The thickness of each edge is commensurate with the corresponding computed probabilities. The COL4A3 protein has the Collagen domain (Collagen in Pfam database; InterPro Database Accession IPR008160) and probably engages PML via its zf-C3HC4 domain (zf-C3HC4 in Pfam database; InterPro Database Accession IPR001841). By way of its Collagen domain, COL4A3 interacts with PITX2 via its Homeobox domain (Homeobox in Pfam database; InterPro Database Accession IPR001356). Among others, there is also a probable interaction between the zf-C3HC4 of PML and the Ankyrin repeat (Ank in Pfam database; InterPro Database Accession IPR002110) domain of CDKN2A that could impact the COPD etiology.
Maximum likelihood estimation indicating probabilities of protein-protein interactions based on evolutionarily conserved domain-domain interactions.
| MLE Probability | ||
| CDKN2A | 0.99 | ETS1 |
| CDKN2A | 1 | NFKBIB |
| CDKN2A | 0.94 | NLRP3 |
| CDKN2A | 1 | NOTCH2 |
| CDKN2A | 1 | PML |
| CDKN2A | 0.99 | TIAL1 |
|
|
|
|
|
|
|
|
| ETS1 | 0.99 | NFKBIB |
| ETS1 | 0.99 | NOTCH2 |
| HSF1 | 0.9 | NFKBIB |
| HSF1 | 0.9 | NOTCH2 |
| JUN | 0.99 | NEUROD1 |
| NEUROD1 | 0.99 | PITX2 |
| NLRP3 | 0.94 | NFKBIB |
| NLRP3 | 0.94 | NOTCH2 |
| NLRP3 | 0.99 | PITX2 |
| NLRP3 | 1 | TIAL1 |
| NOTCH2 | 0.99 | ETS1 |
| NOTCH2 | 1 | NFKBIB |
| NOTCH2 | 1 | PML |
| PML | 1 | JUN |
| PML | 1 | NFKBIB |
| PML | 1 | NOTCH2 |
| PML | 1 | PITX2 |
| TIAL1 | 0.99 | NFKBIB |
| TIAL1 | 0.99 | NOTCH2 |
| TIAL1 | 0.99 | NOTCH2 |
| TIAL1 | 1 | PITX2 |
| TIAL1 | 1 | PITX2 |
| TIAL1 | 1 | PML |
MLE = Maximum likelihood estimation.
Probable interactions involving COL4A3, which is in the susceptibility locus, are in bold character.
Several chromosome 2 genes linked to senescence hubs in transcriptional regulatory network fall within COPD susceptibility locus, 2q33.3–2q37.2.
| Hub | Direct Neighbor | Chromosomal Location |
| CDKN2A | ANXA4 | 2p13 |
|
|
| |
|
|
| |
| IL1A | 2q14 | |
|
|
| |
| TBX3 |
|
|
|
|
| |
| RTKN | 2p13.1 | |
| TIA1 | 2p13 | |
| TBX5 |
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| PRKCE | 2p21 | |
| RHOB | 2p24 | |
| TIA1 | 2p13 |
Genes in bold character are in or border the region of the susceptibility locus.
Several aging-related genes are statistically linked to the expressions of TBX2, CDKN2A, and TGFB1.
| TBX2 | CDKN2A | TGFB1 | |
|
| CTNNA1, CTNND1 | CTNNBIP1 | |
|
| FOXA2, FOXB1, FOXD3, FOXH1, FOX01, FOXO3 | FOXA1, FOXJ1, FOXO4 | |
|
| IGF2, IGF2BP3, IGFBP7, IGFBP5 | IGFALS | IGFALS, IGFBP4, IGF2PB2, IGFBP7, IGFBP5, IGF2R, IGFBP3 |
|
| IL4, IL13, IL13RA1, IL27RA, IL1RL1, IL17RC, IL10RB, IL2RA, IL12RB1 | IL1RN, IL6ST, IL1RAPL1 | IL20RA, IL27RA, IL13RA1, IL2RG, IL10RA, IL4I1 |
|
| WNT3, WNT4, WNT6, WNT7B, WNT11 | WNT10B |
Patient characteristics.
| Characteristic | Normal Samples | COPD Samples |
| GOLD Stage (1/2/3/4) | 15 | 0/9/6/0 |
| Sex (Male/Female) | 15/0 | 15/0 |
| Age (mean ± SD), years | 69.9±14.4 | 68.4±15.1 |
| Pack years smoked, (mean ± SD) | 51.4±11.1 | 58.3±8.3 |
| FEV1 % predicted, (mean ± SD) | 95.1±9.3 | 31.3±29.9 |
| FVC % predicted, (mean ± SD) | 88.7±8.9 | 60.1±18.1 |
FEV1 = Forced expiratory volume at 1 sec; FVC = Function vital capacity; SD = Standard deviation; COPD = Chronic obstructive pulmonary disease.
GOLD (Global Initiative for Chronic Obstructive Lung Disease) Stages:
1 – mild COPD: FEV1≥80% predicted, FEV1:FVC<70%.
2 – moderate COPD: 50%≤FEV1≤80% predicted, FEV1:FVC<70%.
3 – severe COPD: 30%≤FEV1≤50% predicted, FEV1:FVC<70%.
4 – very severe COPD: FEV1<30%predicted or FEV1<50% predicted with chronic respiratory failure, FEV1:FVC<70%.
Pack years: (Packs smoked per day)×(years as a smoker).